Research map: Beyond Hyperglycemia: The Role of Sodium–Glucose Cotransporter 2 Inhibitors in Cancer Treatment-related Cardiac Dysfunction

Back to the article

Papers in this map

  1. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure · Milton Packer · 2020 · 5221 citations · Cited by this paper
  2. Assessing Invasive Coronary Angiography Interpretation Education and Resources · 2025 · Related
  3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines · José Luis Zamorano · 2016 · 2585 citations · Cited by this paper
  4. A Right-atrial Variant of Wild-type Transthyretin Cardiac Amyloidosis · 2025 · Related
  5. Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy · Daniela Maria Cardinale · 2015 · 1763 citations · Cited by this paper
  6. Point-of-care Ultrasound Assessment of the Internal Jugular Vein During Bending in Healthy Individuals · 2025 · Related
  7. Cardiovascular Complications of Cancer Therapy · Edward T.H. Yeh · 2009 · 1288 citations · Cited by this paper
  8. Remote Monitoring in Heart Failure: Revolutionizing Patient Management and Outcomes · 2024 · Related
  9. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study · Joe‐Elie Salem · 2018 · 1266 citations · Cited by this paper
  10. Aortic Endograft Infection: Timely Recognition Is Key · 2025 · Related
  11. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis · Javid J. Moslehi · 2018 · 947 citations · Cited by this paper
  12. Extracorporeal Cardiopulmonary Resuscitation: Life-saving or Resource Wasting? · 2024 · Related
  13. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association · Laxmi S. Mehta · 2018 · 859 citations · Cited by this paper
  14. Navigating Digital Medical Education in the Current Era: Process Over Platform · 2025 · Related
  15. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia · Joerg Herrmann · 2020 · 751 citations · Cited by this paper
  16. Risk Factors for Aortic Dissection · 2023 · Related
  17. Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells · Brian Cameron · 2013 · 700 citations · Cited by this paper
  18. From Abdomen to Atrium: Myxoma Found Incidentally Causing Severe Functional Mitral Stenosis · 2025 · Related
  19. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement · Joerg Herrmann · 2021 · 651 citations · Cited by this paper
  20. Outcomes of Complex Percutaneous Cardiac Interventions in Women · 2023 · Related
  21. Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity · Michael S. Ewer · 2005 · 650 citations · Cited by this paper
  22. Immune checkpoint inhibitors and cardiovascular toxicity · Alexander Richard Lyon · 2018 · 585 citations · Cited by this paper
  23. Cardiovascular toxicities associated with immune checkpoint inhibitors · Jiun‐Ruey Hu · 2019 · 520 citations · Cited by this paper
  24. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management · Sunitha Shyam Sunder · 2023 · 507 citations · Cited by this paper
  25. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy · Cemil Özcelik · 2002 · 475 citations · Cited by this paper
  26. 5-fluorouracil and cardiotoxicity: a review · Jaskanwal Deep Singh Sara · 2018 · 436 citations · Cited by this paper
  27. Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy · Noelle V. Frey · 2018 · 404 citations · Cited by this paper
  28. FDA Approval: Blinatumomab · Donna Przepiorka · 2015 · 375 citations · Cited by this paper
  29. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin · Vincenzo Quagliariello · 2021 · 372 citations · Cited by this paper
  30. Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) · Raza M. Alvi · 2019 · 359 citations · Cited by this paper
  31. Cardiovascular Complications of Cancer Therapy · Hui‐Ming Chang · 2017 · 293 citations · Cited by this paper
  32. Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review · Jorge Ignacio Fonseca-Correa · 2021 · 281 citations · Cited by this paper
  33. Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology · Eve Belzile‐Dugas · 2021 · 273 citations · Cited by this paper
  34. An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors · Teresa Salvatore · 2022 · 260 citations · Cited by this paper
  35. Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy · Zeydin Acar · 2011 · 257 citations · Cited by this paper
  36. Anthracycline Cardiotoxicity in Adult Cancer Patients · Massimiliano Camilli · 2024 · 216 citations · Cited by this paper
  37. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway · Jun Zhou · 2020 · 188 citations · Cited by this paper
  38. Cancer Diagnosis in Patients with Heart Failure: Epidemiology, Clinical Implications and Gaps in Knowledge · Pietro Ameri · 2018 · 186 citations · Cited by this paper
  39. Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies · Bonnie Ky · 2013 · 172 citations · Cited by this paper

Source: OpenAlex (CC0)